Santhera Pharmaceuticals Holding AG (OTCMKTS:SPHDF) Short Interest Update

Santhera Pharmaceuticals Holding AG (OTCMKTS:SPHDF) was the recipient of a large increase in short interest in the month of March. As of March 15th, there was short interest totalling 7,300 shares, an increase of 102.8% from the February 28th total of 3,600 shares. Based on an average daily volume of 100 shares, the short-interest ratio is presently 73.0 days.

Santhera Pharmaceuticals Stock Up 3.4 %

SPHDF stock traded up $0.56 during midday trading on Friday, hitting $17.01. 200 shares of the stock traded hands, compared to its average volume of 333. Santhera Pharmaceuticals has a 1-year low of $16.00 and a 1-year high of $17.01. The stock’s fifty day simple moving average is $11.22 and its 200-day simple moving average is $11.03.

Santhera Pharmaceuticals Company Profile

Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the European Union and internationally. The company's lead pipeline candidate includes Vamorolone, which is being developed for the treatments of Duchenne muscular dystrophy (DMD).